SONN logo

SONN

Profile

Full Name

Sonnet BioTherapeutics Holdings, Inc.

Ticker Symbol

SONN

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

October 31, 2006

Indexes

Not included

Website

http://www.sonnetbio.com

Employees

13

Key Details

Price

$1.26(+2.44%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$18.60K(-87.42% YoY)

Annual EPS

-$11.35(+92.18% YoY)

PE ratio

-

Next earnings date

May 14, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$1.26
SONN price is $1.26

30-Day Relative Volume

0.68
SONN 30-day relative volume is 0.68

Price Performance

Price Most recent change

+2.44%
SONN price was up +2.44% on Apr 17, 2025

Price YTD change

-13.7%
SONN price is down -13.7% since January 1st

Price 1-year change

-90.74%
SONN price is down -90.74% year-on-year

Price 3-year change

-99.85%
SONN price is down -99.85% over the past 3 years

Price Range

Price All-time high

$8008000.00
SONN price is currently -100.00% below its historical high of $8008000.00

Price 3-year low

$0.62
SONN price is currently +103.23% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$3.86M
SONN market capitalization is $3.86 million

Market cap 3-year change

-80.61%
SONN market capitalization is down -80.61% over the past 3 years

Market cap All-time high

$588.65M
SONN market capitalization is currently -99.34% below its historical high of $588.65 million

Market cap sector rank

10.95%
SONN market capitalization is higher than 10.95% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+687.9%
SONN shares outstanding is up +687.9% year-on-year

Shares Outstanding 3-Year Change

+12413.06%
SONN shares outstanding is up +12413.06% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

0.35
SONN beta is 0.35

200-day SMA

$3.73
SONN price is currently -66.20% below its 200-day simple moving average

50-day SMA

$1.41
SONN price is currently -10.35% below its 50-day simple moving average

RSI

43.36
SONN 14-day relative strength index is 43.36

Volume

0.68
SONN 30-day relative volume is 0.68

ATR

$0.11
SONN average true range is $0.11

10-day Historical Volatility

55.27%
SONN 10-day historical volatility is 55.27%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$18.60K
SONN annual revenue is $18.60 thousand

Revenue Analysts estimate

$1.00M
SONN annual revenue is currently -98.14% lower than the consensus analysts' forecast

Revenue 1-year change

-87.42%
SONN annual revenue is down -87.42% year-on-year

Revenue Sector rank

3.24%
SONN annual revenue is higher than 3.24% of companies in Healthcare sector

EPS

EPS

-$11.35
SONN annual earnings per share is -$11.35

EPS Analysts estimate

-$3.46
SONN annual earnings per share is currently +228.03% higher than the consensus analysts' forecast

EPS 1-year change

+92.18%
SONN annual earnings per share is up +92.18% year-on-year

EPS Sector rank

10.87%
SONN annual earnings per share is higher than 10.87% of companies in Healthcare sector

Profit

Gross profit

-
SONN annual gross profit value is unknown

Gross margin

-
SONN annual gross profit margin value is unknown

Operating profit

-$11.85M
SONN annual operating income is -$11.85 million

Operating margin

-63.62K%
SONN annual operating profit margin is -63.62 thousand%

Net income

-$7.44M
SONN annual net profit is -$7.44 million

Net margin

-39.93K%
SONN annual net profit margin is -39.93 thousand%

Expenses

Total expenses

$11.87M
SONN annual total expenses is $11.87 million

Operating expenses

$11.87M
SONN annual total operating expenses is $11.87 million

Cost of goods sold

-
SONN annual cost of goods sold value is unknown

Selling, general & administrative expenses

$6.13M
SONN annual SGA is $6.13 million

Depreciation and amortization

$83.10K
SONN annual depreciation & amortization is $83.10 thousand

Interest expense

-
SONN annual interest expense value is unknown

Income tax

-
SONN annual income tax value is unknown

EBIT & EBITDA

EBIT

-$11.85M
SONN annual earnings before interest & taxes is -$11.85 million

EBITDA

-$11.77M
SONN annual EBITDA is -$11.77 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$2.77M
SONN annual total assets is $2.77 million

Non current assets

$653.10K
SONN annual long term assets is $653.10 thousand

Current assets

$2.12M
SONN annual total current assets is $2.12 million

Cash and cash equivalents

$149.50K
SONN annual cash & cash equivalents is $149.50 thousand

Accounts receivable

-
SONN annual accounts receivable value is unknown

Inventory

-
SONN annual inventory value is unknown

Liabilities

Total liabilities

$3.26M
SONN annual total liabilities is $3.26 million

Long term liabilities

$46.60K
SONN annual total long term liabilities is $46.60 thousand

Current liabilities

$3.21M
SONN annual total current liabilities is $3.21 million

Accounts payable

$2.18M
SONN annual accounts payable is $2.18 million

Debt

Total debt

$130.90K
SONN annual total debt is $130.90 thousand

Total debt 1-year change

-35.8%
SONN annual total debt is down -35.8% year-on-year

Long term debt

$46.60K
SONN annual long term debt is $46.60 thousand

Short term debt

$84.30K
SONN annual short term debt is $84.30 thousand

Equity & Capital

Shareholders equity

-$485.70K
SONN annual stockholders equity is -$485.70 thousand

Book value

-$485.70K
SONN annual book value is -$485.70 thousand

Retained earnings

-$117.68M
SONN annual retained earnings is -$117.68 million

Working capital

-$1.09M
SONN annual working capital is -$1.09 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$8.61M
SONN annual cash flow from operations is -$8.61 million

Cash from operations 1-year change

+59.67%
SONN annual cash flow from operations is up +59.67% year-on-year

Cash from investing

-$12.00K
SONN annual cash flow from investing activities is -$12.00 thousand

Cash from investing 1-year change

+97.29%
SONN annual cash flow from investing activities is up +97.29% year-on-year

Cash from financing

$6.49M
SONN annual cash flow from financing activities is $6.49 million

Cash from financing 1-year change

-69.08%
SONN annual cash flow from financing activities is down -69.08% year-on-year

CAPEX

CAPEX

$12.00K
SONN annual capital expenditures is $12.00 thousand

CAPEX 1-year change

-97.29%
SONN annual capital expenditures is down -97.29% year-on-year

Free Cash Flow

Free cash flow

-$8.62M
SONN annual free cash flow is -$8.62 million

Free cash flow 1-year change

+60.43%
SONN annual free cash flow is up +60.43% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

-
SONN annual gross profit margin value is unknown

Operating margin

-63.62K%
SONN annual operating profit margin is -63.62 thousand%

Net margin

-39.93K%
SONN annual net profit margin is -39.93 thousand%

ROA & ROE

ROA

-181.38%
SONN annual return on assets is -181.38%

ROE

1531.23%
SONN annual return on equity is 1531.23%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
SONN price to earnings ratio value is unknown

PE ratio Sector rank

-
SONN price to earnings ratio is unknown

PB Ratio

PB ratio

0.96
SONN price to book ratio is 0.96

PB ratio Sector rank

43.03%
SONN price to book ratio is higher than 43.03% of companies in Healthcare sector

PS Ratio

PS ratio

3.86
SONN price to sales ratio is 3.86

PS ratio Sector rank

59.97%
SONN price to sales ratio is higher than 59.97% of companies in Healthcare sector

Enterprise value

Enterprise value

-$887.82K
SONN enterprise value is -$887.82 thousand

Enterprise value Sector rank

10.42%
SONN enterprise value is higher than 10.42% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

0.07
SONN EV/EBITDA is 0.07

EV/EBITDA Sector rank

66.38%
SONN EV/EBITDA is higher than 66.38% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

0.66
SONN annual current ratio is 0.66

Quick ratio

-
SONN annual quick ratio value is unknown

Leverage

Debt to equity

0.00
SONN annual debt to equity ratio is 0.00

Interest coverage ratio

-
SONN annual interest coverage ratio value is unknown

Risk & Stability

Piotroski F-Score

-
SONN piotroski f-score value is unknown

Altman Z-Score

-73.32
SONN altman z-score is -73.32

Analyst ratings

Recent major analysts updates

Apr 7, 25 Chardan Capital
Buy
Mar 28, 25 Chardan Capital
Buy
Dec 20, 24 Chardan Capital
Buy
Aug 23, 24 Chardan Capital
Buy
May 28, 24 Chardan Capital
Buy
May 16, 24 EF Hutton
Buy
Feb 15, 24 Chardan Capital
Buy
Nov 27, 23 Ladenburg Thalmann
Buy
Aug 16, 23 Chardan Capital
Buy
Jun 26, 23 EF Hutton
Buy

Institutional Ownership

Similar stocks

PRFX logo
PainReform (PRFX)
OGEN logo
Oragenics (OGEN)
CHEK logo
Check-Cap (CHEK)
TOVX logo
Theriva Biologics (TOVX)
DRMA logo
Dermata Therapeutics (DRMA)
RDHL logo
RedHill Biopharma (RDHL)
RHE logo
Regional Health Properties (RHE)
TCRT logo
Alaunos Therapeutics (TCRT)
XBIO logo
Xenetic Biosciences (XBIO)
  • What is the ticker symbol for Sonnet BioTherapeutics Holdings?
  • Does Sonnet BioTherapeutics Holdings pay dividends?
  • What sector is Sonnet BioTherapeutics Holdings in?
  • What industry is Sonnet BioTherapeutics Holdings in?
  • What country is Sonnet BioTherapeutics Holdings based in?
  • When did Sonnet BioTherapeutics Holdings go public?
  • Is Sonnet BioTherapeutics Holdings in the S&P 500?
  • Is Sonnet BioTherapeutics Holdings in the NASDAQ 100?
  • Is Sonnet BioTherapeutics Holdings in the Dow Jones?
  • When was Sonnet BioTherapeutics Holdings's last earnings report?
  • When does Sonnet BioTherapeutics Holdings report earnings?
  • Should I buy Sonnet BioTherapeutics Holdings stock now?

What is the ticker symbol for Sonnet BioTherapeutics Holdings?

The ticker symbol for Sonnet BioTherapeutics Holdings is NASDAQ:SONN

Does Sonnet BioTherapeutics Holdings pay dividends?

No, Sonnet BioTherapeutics Holdings does not pay dividends

What sector is Sonnet BioTherapeutics Holdings in?

Sonnet BioTherapeutics Holdings is in the Healthcare sector

What industry is Sonnet BioTherapeutics Holdings in?

Sonnet BioTherapeutics Holdings is in the Biotechnology industry

What country is Sonnet BioTherapeutics Holdings based in?

Sonnet BioTherapeutics Holdings is headquartered in United States

When did Sonnet BioTherapeutics Holdings go public?

Sonnet BioTherapeutics Holdings's initial public offering (IPO) was on October 31, 2006

Is Sonnet BioTherapeutics Holdings in the S&P 500?

No, Sonnet BioTherapeutics Holdings is not included in the S&P 500 index

Is Sonnet BioTherapeutics Holdings in the NASDAQ 100?

No, Sonnet BioTherapeutics Holdings is not included in the NASDAQ 100 index

Is Sonnet BioTherapeutics Holdings in the Dow Jones?

No, Sonnet BioTherapeutics Holdings is not included in the Dow Jones index

When was Sonnet BioTherapeutics Holdings's last earnings report?

Sonnet BioTherapeutics Holdings's most recent earnings report was on Feb 13, 2025

When does Sonnet BioTherapeutics Holdings report earnings?

The next expected earnings date for Sonnet BioTherapeutics Holdings is May 14, 2025

Should I buy Sonnet BioTherapeutics Holdings stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page